In particular, corylin, a flavonoid compound extracted from Psoralea corylifolia L., has been shown to stimulate osteoblast proliferation [10], attenuate lipopolysaccharide (LPS)- or interleukin-6 (IL-6)-induced inflammatory responses [11,12], suppress hepatocellular carcinoma progression [13], ameliorates hyperlipidemia, insulin resistance and atherosclerosis [14] and increase hepatocellular carcinoma cell sensitivity to chemotherapy and radiotherapy [15]. Here, IL6 is linked to hyperlipidemia.